ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers

October 9, 1998

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

Congress Approves FY 1980 HEW Funds

November 23, 1979